Home/Filings/4/0001062993-25-000236
4//SEC Filing

Lask Alisa 4

Accession 0001062993-25-000236

CIK 0001196298other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 5:08 PM ET

Size

13.5 KB

Accession

0001062993-25-000236

Insider Transaction Report

Form 4
Period: 2025-01-01
Lask Alisa
Director
Transactions
  • Award

    Stock Option (right to buy)

    2025-01-01+7,0507,050 total
    Exercise: $1.47Exp: 2035-01-01Common Stock (7,050 underlying)
Holdings
  • Stock Option (right to buy)

    Exercise: $8.57Exp: 2029-12-16Common Stock (5,568 underlying)
    5,568
  • Stock Option (right to buy)

    Exercise: $1.07Exp: 2033-01-05Common Stock (7,080 underlying)
    7,080
  • Stock Option (right to buy)

    Exercise: $6.82Exp: 2031-12-14Common Stock (7,062 underlying)
    7,062
  • Common Stock

    48,629
  • Stock Option (right to buy)

    Exercise: $2.14Exp: 2034-05-14Common Stock (7,323 underlying)
    7,323
  • Stock Option (right to buy)

    Exercise: $5.22Exp: 2029-02-08Common Stock (9,617 underlying)
    9,617
  • Stock Option (right to buy)

    Exercise: $8.06Exp: 2031-01-06Common Stock (6,850 underlying)
    6,850
Footnotes (4)
  • [F1]Fully exercisable.
  • [F2]This option vests as to 2,360 shares on each of 1/5/23, 1/5/24 and 1/5/25.
  • [F3]This option vests as to 2,441 shares on each of 5/14/24, 5/14/25 and 5/14/26.
  • [F4]Represents options granted to the reporting person for her service on the Company's Board of Directors for 2024. This option vests as to 2,350 shares on each of 1/1/25, 1/1/26 and 1/1/27.

Issuer

NEPHROS INC

CIK 0001196298

Entity typeother

Related Parties

1
  • filerCIK 0001767593

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:08 PM ET
Size
13.5 KB